$24.63
-0.54 (-2.15%)
Performance
1D
—
1W
—
1M
—
3M
-11.97%
6M
+3.01%
1Y
+12.41%
YTD
-9.25%
Open$25.06
Previous Close$25.17
Day High$25.82
Day Low$24.60
52W High$36.44
52W Low$13.53
Volume—
Avg Volume1.50M
Market Cap2.83B
P/E Ratio—
EPS$-4.43
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$28.48
Below
SMA 200
$22.69
Above
RSI (14)
44
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
25 analysts
Price Target
+152.0% upside
Current
$24.63
$24.63
Target
$62.07
$62.07
$37.88
$62.07 avg
$80.69
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 80.30M | 75.04M | 476.44M |
| Net Income | -476,226,747 | -400,527,121 | -46,993,180 |
| Profit Margin | -593.1% | -563.5% | -9.9% |
| EBITDA | -495,580,060 | -439,959,870 | -41,088,618 |
| Free Cash Flow | — | — | -33,034,013 |
| Rev Growth | +7.0% | +7.0% | -6.6% |
| Debt/Equity | — | — | 0.22 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |